Does ADT Cause Death from Myocardial Infarctions?
According to an article published in URO Today the belief that adjuvant androgen suppression therapy (AST) is associated with early deaths due to myocardial infarctions (MCIs) is not true. The belief that ASTs increases deaths [...]
The Latest News about MDV3100 (Enzalutamide) – We Believe that Its FDA Approval is Just Around the Corner
My very dear friend and advocate supreme, Jan Manarite, from PCRI has sent me an update on MDV3100 (enzalutamide). As usual her information is important, so I thought I would pass it on today. • [...]
No PSA Test Means More Men will be Diagnosed with A Terminal Illness, Advanced Prostate Cancer
Finally, we are getting a little common sense discussion about the role of PSA screening. Not to beat a dead horse, but as we all know the United Sates Preventive Task Force (USPTF) changed their [...]
AUA 2012 – The Absence of Goal Setting in the Dialogue between Men with Advanced Prostate Cancer and their Doctors
What are our goals as advanced prostate cancer survivors and what are the goals of our oncologists? Often they are not the same! This misalignment between our expectations and those of our clinicians is common, [...]
Two Early Access Trials – 2 New sites for MDV-3100 & A New Early Access Trial for Radium-223 Chloride (Alpharedin)
There has been a lot of news in the area of early access for great drugs to treat advanced prostate cancer prior to the FDA’s approval. I have informed you about the Early Access Program [...]
Hormone Therapy Will Only Last for A Short Time – A Myth Worthy of Being Debunked
One of the more common myths about hormone therapy (ADT) to treat prostate cancer is that its effectiveness will last only for one and a half to two years. For some men this might be [...]